Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.1938
+0.0096 (5.21%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Ernexa Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 1.73 | 7.58 | 11.45 | 16.99 | 1.63 | Upgrade
|
| Cash & Short-Term Investments | 1.73 | 7.58 | 11.45 | 16.99 | 1.63 | Upgrade
|
| Cash Growth | -77.18% | -33.82% | -32.61% | 942.02% | -67.50% | Upgrade
|
| Other Receivables | 0.44 | 0.43 | 0.95 | 0.68 | - | Upgrade
|
| Receivables | 0.44 | 0.43 | 0.95 | 0.68 | - | Upgrade
|
| Prepaid Expenses | 0.19 | 1.6 | 1.28 | 1.1 | 0.1 | Upgrade
|
| Total Current Assets | 2.35 | 9.6 | 13.68 | 18.77 | 1.73 | Upgrade
|
| Property, Plant & Equipment | 0.76 | 33.27 | 1.27 | 3.24 | 2.69 | Upgrade
|
| Long-Term Investments | - | - | 0.06 | 1 | - | Upgrade
|
| Goodwill | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 5.99 | 5.99 | Upgrade
|
| Other Long-Term Assets | 0.12 | 4.22 | 5.23 | 0.49 | 0.45 | Upgrade
|
| Total Assets | 5.27 | 49.13 | 22.28 | 31.53 | 12.91 | Upgrade
|
| Accounts Payable | 1.72 | 1.07 | 1.62 | 1.76 | 1.28 | Upgrade
|
| Accrued Expenses | 1.01 | 2.88 | 4.1 | 1.01 | 1.05 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.41 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.12 | Upgrade
|
| Current Portion of Leases | 0.21 | 2.22 | 0.3 | 0.43 | 0.27 | Upgrade
|
| Current Income Taxes Payable | 0 | 0 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | 0.19 | - | - | - | Upgrade
|
| Other Current Liabilities | - | 0.22 | 1.64 | 0.49 | - | Upgrade
|
| Total Current Liabilities | 2.94 | 6.57 | 7.65 | 3.68 | 3.13 | Upgrade
|
| Long-Term Debt | - | 6.77 | - | - | 0.19 | Upgrade
|
| Long-Term Leases | 0.48 | 32.85 | 0.89 | 2.3 | 1.91 | Upgrade
|
| Long-Term Unearned Revenue | - | 0.39 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.15 | 0.31 | 1.63 | 0.05 | 0.02 | Upgrade
|
| Total Liabilities | 3.57 | 46.9 | 10.17 | 6.02 | 5.25 | Upgrade
|
| Common Stock | 0.26 | 0.03 | 0.03 | 0.01 | 25.8 | Upgrade
|
| Additional Paid-In Capital | 232.98 | 189.19 | 177.38 | 166.19 | - | Upgrade
|
| Retained Earnings | -231.54 | -186.98 | -165.3 | -140.7 | -18.14 | Upgrade
|
| Total Common Equity | 1.7 | 2.23 | 12.11 | 25.5 | 7.66 | Upgrade
|
| Shareholders' Equity | 1.7 | 2.23 | 12.11 | 25.5 | 7.66 | Upgrade
|
| Total Liabilities & Equity | 5.27 | 49.13 | 22.28 | 31.53 | 12.91 | Upgrade
|
| Total Debt | 0.68 | 41.84 | 1.18 | 2.72 | 2.9 | Upgrade
|
| Net Cash (Debt) | 1.05 | -34.27 | 10.26 | 14.26 | -1.27 | Upgrade
|
| Net Cash Growth | - | - | -28.03% | - | - | Upgrade
|
| Net Cash Per Share | 0.08 | -6.45 | 3.36 | 6.59 | -1.44 | Upgrade
|
| Filing Date Shares Outstanding | 52.24 | 5.41 | 5.13 | 2.87 | 0.88 | Upgrade
|
| Total Common Shares Outstanding | 51.39 | 5.41 | 5.13 | 2.6 | 0.88 | Upgrade
|
| Working Capital | -0.59 | 3.03 | 6.03 | 15.09 | -1.39 | Upgrade
|
| Book Value Per Share | 0.03 | 0.41 | 2.36 | 9.80 | 8.68 | Upgrade
|
| Tangible Book Value | -0.34 | 0.19 | 10.06 | 23.46 | 5.62 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | 0.03 | 1.96 | 9.02 | 6.37 | Upgrade
|
| Machinery | 0.26 | 0.33 | 0.27 | 0.41 | 0.3 | Upgrade
|
| Leasehold Improvements | - | 0.27 | - | 0.46 | 0.41 | Upgrade
|
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.